18431-7 |
Amphetamines |
PrThr |
Stool |
Pt |
Ord |
Screen |
|
ACTIVE |
Amphetamines [Presence] in Stool by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
18431-7 |
|
Screen |
|
|
Both |
|
|
|
0 |
Amphetamines Stl Ql Scn |
|
|
|
|
|
Addiction; Amph; Amphetam; Amphetamine; Bowel movement; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Faecal; Faeces; Fecal; Feces; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Speed; Stl; Stool = Fecal |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
18432-5 |
Tetrahydrocannabinol |
PrThr |
Stool |
Pt |
Ord |
Screen |
|
ACTIVE |
Tetrahydrocannabinol [Presence] in Stool by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
18432-5 |
|
Screen |
|
|
Both |
|
|
|
0 |
THC Stl Ql Scn |
|
|
|
|
|
Bowel movement; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Dronabinol; DRUG/TOXICOLOGY; Drugs; Faecal; Faeces; Fecal; Feces; Marijuana; Nabilone; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Stl; Stool = Fecal; THC |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
18433-3 |
1,3-Dichlorobenzene |
MCnc |
Bld |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated 1,3-Dichlorobenzene [Mass/volume] in Blood |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
18433-3 |
|
|
|
|
|
|
|
|
0 |
Deprecated 1,3DCB Bld-mCnc |
|
|
|
Y |
|
1,3-D; 1,3DCB; 3,3'-dichlorobenzidine; Blood; DCB; DRUG/TOXICOLOGY; Drugs; i; III; Level; Mass concentration; m-Dichlorobenzene; m-dichlorobenzol; Metadichlorobenzene; m-Phenylenedichloride; Point in time; QNT; Quan; Quant; Quantitative; Random; Telone; WB; Whole blood |
2.36 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
18434-1 |
1,2-Dichlorobenzene |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
1,2-Dichlorobenzene [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
18434-1 |
|
|
|
|
Observation |
|
|
|
0 |
1,2DCB Bld-mCnc |
|
|
|
Y |
|
1,2DCB; 3,3'-dichlorobenzidine; Blood; DCB; DRUG/TOXICOLOGY; Drugs; i; II; Level; Mass concentration; ODCB; o-dichlorobenzene; ortho-dichlorobenzene; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1.0l |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
18435-8 |
SUFentanil |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
SUFentanil [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
18435-8 |
|
|
|
|
Both |
|
|
|
0 |
SUFentanil Ur Ql |
|
|
|
|
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Sufenta; UA; UR; Urn |
2.56 |
1.0l |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
18436-6 |
Acetylcarnitine (C2) |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Acetylcarnitine (C2) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
18436-6 |
|
|
|
|
Both |
|
|
|
0 |
Acetylcarn SerPl-mCnc |
|
|
|
Y |
|
C2; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
18437-4 |
Acrylylcarnitine (C3:1) |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Acrylylcarnitine (C3:1) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
18437-4 |
|
|
|
|
Observation |
|
|
|
0 |
Acrylylcarn SerPl-mCnc |
|
|
|
Y |
|
C3:1; Chemistry; i; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Propenoylcarnitine; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
18438-2 |
Propionylcarnitine (C3) |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Propionylcarnitine (C3) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
18438-2 |
|
|
|
|
Observation |
|
|
|
0 |
Propionylcarn SerPl-mCnc |
|
|
|
Y |
|
C3; C3-carntitine; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Propanoylcarnitine; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
18439-0 |
Butyrylcarnitine (C4) |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Butyrylcarnitine (C4) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
18439-0 |
|
|
|
|
Observation |
|
|
|
0 |
Butyrylcarn SerPl-mCnc |
|
|
|
Y |
|
C4; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
1844-0 |
Ammonium ion |
SCnc |
BldA |
Pt |
Qn |
|
|
ACTIVE |
Ammonium ion [Moles/volume] in Arterial blood |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
1844-0 |
|
|
|
|
Both |
|
|
|
0 |
Ammonium Ion BldA-sCnc |
|
|
|
Y |
|
ABG; Amm; Ammon; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Level; NH4; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.42 |
1 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
18440-8 |
Crotonylcarnitine (C4:1) |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Crotonylcarnitine (C4:1) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
18440-8 |
|
|
|
|
Observation |
|
|
|
0 |
Crotonylcarn SerPl-mCnc |
|
|
|
Y |
|
C4:1; Chemistry; i; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.42 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
18441-6 |
Isovalerylcarnitine (C5) |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Isovalerylcarnitine (C5) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
18441-6 |
|
|
|
|
Observation |
|
|
|
0 |
Isovalerylcarn SerPl-mCnc |
|
|
|
Y |
|
C5; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
18442-4 |
3-Hydroxybutyrylcarnitine (C4-OH) |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
3-Hydroxybutyrylcarnitine (C4-OH) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
18442-4 |
|
|
|
|
Observation |
|
|
|
0 |
3OH-Butyrcarn SerPl-mCnc |
|
|
|
Y |
|
3-Hydroxy butyrylcarnitine; 3-hydroxybutylcarnitine; 3-hydroxy-butylcarnitine; 3OH-Butyrcarn; C4OH; C4-OH; Chemistry; III; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
18443-2 |
Hexanoylcarnitine (C6) |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Hexanoylcarnitine (C6) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
18443-2 |
|
|
|
|
Observation |
|
|
|
0 |
Hexanoylcarn SerPl-mCnc |
|
|
|
Y |
|
C6; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
18444-0 |
3-Hydroxyisovalerylcarnitine (C5-OH) |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
3-Hydroxyisovalerylcarnitine (C5-OH) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
18444-0 |
|
|
|
|
Observation |
|
|
|
0 |
3OH-Isovalerylcarn SerPl-mCnc |
|
|
|
Y |
|
3-hydroxy-isovalerylcarnitine; 3OH-Isovalerylcarn; C5OH; C5-OH; Chemistry; III; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
18445-7 |
Benzoylcarnitine (BzCn) |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Benzoylcarnitine (BzCn) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
18445-7 |
|
|
|
|
Observation |
|
|
|
0 |
Benzoylcarn SerPl-mCnc |
|
|
|
Y |
|
BzCn; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
18446-5 |
Methylmalonylcarnitine (C4-DC) |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Methylmalonylcarnitine (C4-DC) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
18446-5 |
|
|
|
|
Observation |
|
|
|
0 |
Me-malonylcarn SerPl-mCnc |
|
|
|
Y |
|
C4DC; C4-DC; C4-DCC; Chemistry; Dicarboxylic carnitine; Level; Mass concentration; Me-malonylcarn; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
18447-3 |
Octenoylcarnitine (C8:1) |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Octenoylcarnitine (C8:1) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
18447-3 |
|
|
|
|
Observation |
|
|
|
0 |
Octenoylcarn SerPl-mCnc |
|
|
|
Y |
|
C8:1; Chemistry; i; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
18448-1 |
Octanoylcarnitine (C8) |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Octanoylcarnitine (C8) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
18448-1 |
|
|
|
|
Observation |
|
|
|
0 |
Octanoylcarn SerPl-mCnc |
|
|
|
Y |
|
C8; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
18449-9 |
Glutarylcarnitine (C5-DC) |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Glutarylcarnitine (C5-DC) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
18449-9 |
|
|
|
|
Observation |
|
|
|
0 |
Glutarylcarn SerPl-mCnc |
|
|
|
Y |
|
C5DC; C5-DC; Chemistry; Dicarboxylic carnitine; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
1845-7 |
Ammonium ion |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Ammonium ion [Moles/volume] in Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
1845-7 |
|
|
|
|
Both |
|
|
|
0 |
Ammonium Ion Plas-sCnc |
|
|
|
Y |
|
Amm; Ammon; Chemistry; Level; NH4; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.34 |
1 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
18450-7 |
Adipoylcarnitine (C6-DC) |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Adipoylcarnitine (C6-DC) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
18450-7 |
|
|
|
|
Observation |
|
|
|
0 |
Adipoylcarn SerPl-mCnc |
|
|
|
Y |
|
Adipylcarnitine; C6DC; C6-DC; Chemistry; Dicarboxylic carnitine; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
18451-5 |
Cis-4-decenoylcarnitine (Cis 4 C10:1) |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
cis-4-Decenoylcarnitine (Cis 4 C10:1) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
18451-5 |
|
|
|
|
Observation |
|
|
|
0 |
Cis4Decenoylcarn SerPl-mCnc |
|
|
|
Y |
|
Chemistry; Cis4Decenoylcarn; i; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.42 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
18452-3 |
Decanoylcarnitine (C10) |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Decanoylcarnitine (C10) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
18452-3 |
|
|
|
|
Observation |
|
|
|
0 |
Decanoylcarn SerPl-mCnc |
|
|
|
Y |
|
C10; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
18453-1 |
Suberylcarnitine (C8-DC) |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Suberylcarnitine (C8-DC) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
18453-1 |
|
|
|
|
Observation |
|
|
|
0 |
Suberylcarn SerPl-mCnc |
|
|
|
Y |
|
C8DC; C8-DC; Chemistry; Dicarboxylic carnitine; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0l |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |